Europe Biomarkers Market by Product (Consumables, Services, & Software), Type (Safety Biomarkers, Efficacy Biomarkers), Application (Diagnostics, Drug Discovery), and Disease Indications (Cancer, Cardiovascular) – Market Analysis, Size, Geographic Countries Analysis, Competitive Strategies Analysis and Forecasts (2016 to 2021)

Europe Biomarkers Market by Product (Consumables, Services, & Software), Type (Safety Biomarkers, Efficacy Biomarkers), Application (Diagnostics, Drug Discovery), and Disease Indications (Cancer, Cardiovascular) – Market Analysis, Size, Geographic Countries Analysis, Competitive Strategies Analysis and Forecasts (2016 to 2021)

ID: 194 | Pages: 138 | December 2016 | Region: Europe


Europe biomarkers market is expected to reach USD 13.06 billion by 2020 from USD 7.12 billion in 2015, growing at a CAGR of 12.90% during forecast period 2015-2020. Biomarkers are described as the biological molecules or genes assist in crucial clinical decisions and diagnosis of health conditions in patients. These are also known as molecular markers or signature molecules and used to analyze the pharmacologic responses, biological & pathological conditions. Biomarkers are found extensively in body fluids and tissues. Biomarkers are helpful in drug discovery & development processes and assessment of disease conditions.

Increasing healthcare expenditure, growing aging population, rising number of cancer patients, growing demand for diagnostics, increasing awareness on healthy lifestyle are driving the growth of biomarkers market in Europe. In addition, increasing utilization of biomarkers in clinical trials & drug discovery and growing technologies in biomarkers discovery are further stimulating the growth of biomarkers market in Europe. However, requirement of qualitative biomarkers validation and high cost of the biomarkers development are expected to restrain the growth of biomarkers market in Europe.

Europe biomarkers market is segmented based on the product, type, application, and disease indications. Based on product, the market is further sub-segmented as consumables, software, and services. Based on type, the market is segmented as safety biomarkers, efficacy biomarkers, and validation biomarkers. Biomarkers application is further segmented as diagnostics developments, drug discovery & developments, personalized medicine, and disease risk assessment. Based on disease indications, the market is segmented as cancer, cardiovascular, neurological, and immunological disorders.

On the basis of geographical areas, Europe biomarkers market is segmented as U.K., Germany, France, Italy, and Spain.

The key players in biomarkers market include, Bio-Rad Laboratories (U.S.), Qiagen N.V. (Netherlands), Enzo Biochem (U.S.), PerkinElmer, Inc. (U.S.), Merck & Co, Inc. (U.S.), EKF Diagnostics Holdings plc. (U.S.), Meso Scale Diagnostics, LLC (U.S.), Singulex, Inc. (U.S.), BioSims Technologies (France), Cisbio Bioassays (France), and Signosis, Inc. (U.S.).

  1. Introduction

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

  1. Research Methodology

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

  1. Overview

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 New Developments                                                               

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

  1. Market Segmentation

                5.1          Product                                               

                                5.1.1 Introduction                                           

                                5.1.2 Consumables                                         

                                5.1.3 Software                                  

                                5.1.4 Services     Growth Hormone Therapy                         

                5.2          Type                                     

                                5.2.1 Introduction                                           

                                5.2.2 Safety Biomarkers                                               

                                5.2.3 Efficacy Biomarkers                                             

                                5.2.4 Validation Biomarkers                                        

                5.3          Application                                        

                                5.3.1 Introduction                                           

                                5.3.2 Diagnostics Development                                 

                                5.3.3 Drug Discovery and Development                                

                                5.3.4 Personalised Medicine                                      

                                5.3.5 Disease Risk Assessment                                  

                                5.3.6 Other Applications                                               

                5.4          Disease Indications                                        

                                5.4.1 Introduction                                           

                                5.4.2 Cancer                                      

                                5.4.3 CardiovascularDisorders                                    

                                5.4.4 Neurological Disorders                                       

                                5.4.5 Immunological Disorders                                  

                                5.4.6 Other Diseases                                      

  1. Geographical Analysis

                                6.1 Introduction                                               

                                6.2 U.K                                 

                                6.3 Spain                                             

                                6.4 Germany                                     

                                6.5 Italy                                               

                                6.6 France                                          

  1. Strategic Analysis

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

  1. Market Leaders' Analysis

                8.1 Bio-Rad Laboratories (U.S.)                                 

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Strategic Evaluation and Operations                                            

                                8.1.4 Financial analysis                                  

                                8.1.5 Legal issues                                             

                                8.1.6 Recent Developments                                       

                                8.1.7 SWOT analysis                                       

                                8.1.8 Analyst View                                          

                8.2 Qiagen N.V. (Netherlands)                                  

                8.3 Enzo Biochem (U.S.)                                               

                8.4 PerkinElmer, Inc. (U.S.)                                         

                8.5 Merck & Co, Inc. (U.S.)                                          

                8.6 EKF Diagnostics Holdings plc. (U.S.)                                  

                8.7 Meso Scale Diagnostics, LLC (U.S.)                                    

                8.8 Singulex, Inc. (U.S.)                                 

                8.9 BioSims Technologies (France)                                           

                8.10 Cisbio Bioassays (France)                                   

                8.11 Signosis, Inc. (U.S.)                                               

  1. Competitive Landscape

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

  1. Expert Opinions

                10.1 Market Outlook                                                     

                10.2 Investment Opportunities                                                 

     Appendix                                                                           

  1. List of Tables
  2. List of Figures
  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Europe Biomarkers Market By Region, From 2015-2020 ( USD Billion )
  2. Europe Biomarkers Market By Product, From 2015-2020 ( USD Billion )
  3. Europe Consumables Market By Region, From 2015-2020 ( USD Billion )
  4. Europe Software Market By Region, From 2015-2020 ( USD Billion )
  5. Europe Services Market By Region, From 2015-2020 ( USD Billion )
  6. Europe Biomarkers Market By Type, From 2015-2020 ( USD Billion )
  7. Europe Safety Biomarkers Market By Region, From 2015-2020 ( USD Billion )
  8. Europe Efficacy Biomarkers Market By Region, From 2015-2020 ( USD Billion )
  9. Europe Validation Biomarkers Market By Region, From 2015-2020 ( USD Billion )
  10. Europe Biomarkers Market By Application, From 2015-2020 ( USD Billion )
  11. Europe Diagnostics Development Market By Region, From 2015-2020 ( USD Billion )
  12. Europe Drug Discovery and Development Market By Region, From 2015-2020 ( USD Billion )
  13. Europe Personalised Medicine Market By Region, From 2015-2020 ( USD Billion )
  14. Europe Disease Risk Assessment Market By Region, From 2015-2020 ( USD Billion )
  15. Europe Other Applications Market By Region, From 2015-2020 ( USD Billion )
  16. Europe Biomarkers Market By Disease Indications, From 2015-2020 ( USD Billion )
  17. Europe Cancer Market By Region, From 2015-2020 ( USD Billion )
  18. Europe Cardiovascular Disorders Market By Region, From 2015-2020 ( USD Billion )
  19. Europe Neurological Disorders Market By Region, From 2015-2020 ( USD Billion )
  20. Europe Immunological Disorders Market By Region, From 2015-2020 ( USD Billion )
  21. Europe Other Diseases Market By Region, From 2015-2020 ( USD Billion )
  22. U.K. Biomarkers Market By Product, From 2015-2020 ( USD Billion )
  23. U.K. Biomarkers Market By Type, From 2015-2020 ( USD Billion )
  24. U.K. Biomarkers Market By Application, From 2015-2020 ( USD Billion )
  25. U.K. Biomarkers Market By Disease Indications, From 2015-2020 ( USD Billion )
  26. Germany Biomarkers Market By Product, From 2015-2020 ( USD Billion )
  27. Germany Biomarkers Market By Type, From 2015-2020 ( USD Billion )
  28. Germany Biomarkers Market By Application, From 2015-2020 ( USD Billion )
  29. Germany Biomarkers Market By Disease Indications, From 2015-2020 ( USD Billion )
  30. France Biomarkers Market By Product, From 2015-2020 ( USD Billion )
  31. France Biomarkers Market By Type, From 2015-2020 ( USD Billion )
  32. France Biomarkers Market By Application, From 2015-2020 ( USD Billion )
  33. France Biomarkers Market By Disease Indications, From 2015-2020 ( USD Billion )
  34. Italy Biomarkers Market By Product, From 2015-2020 ( USD Billion )
  35. Italy Biomarkers Market By Type, From 2015-2020 ( USD Billion )
  36. Italy Biomarkers Market By Application, From 2015-2020 ( USD Billion )
  37. Italy Biomarkers Market By Disease Indications, From 2015-2020 ( USD Billion )
  38. Spain Biomarkers Market By Product, From 2015-2020 ( USD Billion )
  39. Spain Biomarkers Market By Type, From 2015-2020 ( USD Billion )
  40. Spain Biomarkers Market By Application, From 2015-2020 ( USD Billion )
  41. Spain Biomarkers Market By Disease Indications, From 2015-2020 ( USD Billion )
Middle-East and Africa Cancer Biomarkers Market by Disease (Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer and Other Cancers), by Services (Sample Preparation, Assay development and ...
Latin America Cancer Biomarkers Market by Disease (Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer and Other Cancers), by Services (Sample Preparation, Assay development and Biomarker...
Asia-Pacific Cancer Biomarkers Market by Disease (Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer and Other Cancers), by Services (Sample Preparation, Assay development and Biomarkers...
Europe Cancer Biomarkers Market by Disease (Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer and Other Cancers), by Services (Sample Preparation, Assay development and Biomarkers valid...
North America Cancer Biomarkers Market by Disease (Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer and Other Cancers), by Services (Sample Preparation, Assay development and Biomarker...
Cancer Biomarkers Market by Disease (Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer and Other Cancers), by Services (Sample Preparation, Assay development and Biomarkers validation a...
Middle East and Africa Biomarkers Market by Product (Consumables, Services, & Software), Type (Safety Biomarkers, Efficacy Biomarkers), Application (Diagnostics, Drug Discovery), and Disease Indications (Cancer, Car...
Latin America Biomarkers Market by Product (Consumables, Services, & Software), Type (Safety Biomarkers, Efficacy Biomarkers), Application (Diagnostics, Drug Discovery), and Disease Indications (Cancer, Cardiovascul...
Asia-Pacific Biomarkers Market by Product (Consumables, Services, & Software), Type (Safety Biomarkers, Efficacy Biomarkers), Application (Diagnostics, Drug Discovery), and Disease Indications (Cancer, Cardiovascula...
Europe Biomarkers Market by Product (Consumables, Services, & Software), Type (Safety Biomarkers, Efficacy Biomarkers), Application (Diagnostics, Drug Discovery), and Disease Indications (Cancer, Cardiovascular) –...
North America Biomarkers Market by Product (Consumables, Services, & Software), Type (Safety Biomarkers, Efficacy Biomarkers), Application (Diagnostics, Drug Discovery), and Disease Indications (Cancer, Cardiovascul...
Biomarkers Market by Product (Consumables, Services, & Software), Type (Safety Biomarkers, Efficacy Biomarkers), Application (Diagnostics, Drug Discovery), and Disease Indications (Cancer, Cardiovascular) - Global M...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
502, Kakatiya's Empire,
Jubilee Gardens, Hyderabad,
Telangana, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.